Olivia C Ware's Net Worth
$1.22 Million
Who is Olivia C Ware?
Olivia C Ware has an estimated net worth of $1.22 Million. This is based on reported shares across multiple companies, which include Revance Therapeutics, Inc., CYTRX CORP, Arcellx, Inc., and Contineum Therapeutics, Inc..
SEC CIK
Olivia C Ware's CIK is 0001663771
Past Insider Trading and Trends
2024 was Olivia C Ware's most active year for acquiring shares with 6 total transactions. Olivia C Ware's most active month to acquire stocks was the month of April. 2024 was Olivia C Ware's most active year for disposing of shares, totalling 7 transactions. Olivia C Ware's most active month to dispose stocks was the month of February. 2024 saw Olivia C Ware paying a total of $140,039.22 for 68,571 shares, this is the most they've acquired in one year. In 2024 Olivia C Ware cashed out on 36,804 shares for a total of $1,155,841.51, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Revance Therapeutics, Inc. (RVNC) Snapshot price: $6.56
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +89.96% | 15K |
—
|
—
| 31.68K |
May 1
| |||
Form 4
| +26.89% | 3.53K |
—
|
—
| 16.68K |
May 3
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
| +85.55% | 6.06K |
—
|
—
| 13.14K |
May 4
| |||
Form 4
| +10.52% | 674 |
—
|
—
| 7.08K |
May 5
| |||
Form 4
|
∞
| 6.41K |
—
|
—
| 6.41K |
Mar 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CYTRX CORP (LADX) Snapshot price: $1.5
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcellx, Inc. (ACLX) Snapshot price: $71.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
$31.58 | -$450,710.37 |
0
|
Scheduled
|
Apr 16
| ||
Form 4
|
—
|
0
|
$39.01 | -$565,091.93 |
0
|
Scheduled
|
Mar 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Contineum Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||